News Agency
The Times

The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration

  • Written by Media Outreach
HONG KONG SAR - Media OutReach Newswire - 18 November 2024 - AIM Vaccine (06660.HK), the world's second largest supplier of rabies vaccines, announced on 17th November that The pre-application for marketing registration of the iterative serum-free rabies vaccine independently developed by the Company has been submitted to the National Medical...

Read more: The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has...

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion